A Product and Pipeline Analysis of the Human Plasma-derived Therapeutics Market

Launch of Novel Immunoglobulin Products and Increasing Awareness of Therapeutic Options to Drive Double-digit Market Growth


RELEASE DATE
08-Dec-2015
REGION
Asia Pacific
DELIVERABLE TYPE
Market Research

RESEARCH CODE
MAEC-01-00-00-00
SKU
LS00108-AP-MR_16949
Yes
SHARE

A Product and Pipeline Analysis of the Human Plasma-derived Therapeutics Market
Published on: 08-Dec-2015 | SKU: LS00108-AP-MR_16949

Need more details?

$6,000.00

$4,500.00 save 25 %

DownloadLink
Need more details?

The global human plasma-derived therapeutics market is expected to experience a surge in demand due to an increase in the awareness of diseases and therapeutic options. The plasma-derived therapeutics market is segmented into albumin, immunoglobulins, coagulation factors, and other haemotologicals. The segments are discussed with supporting information on clinical trial timelines and results and historical and projected launch timelines. The report also focuses on the competitive landscape of both marketed and pipeline products and provides the market drivers and challenges.

Executive Summary

Recent Market Developments

Key M&As and Partnership Assessment

Companies to Watch

Methodology and Scope

Market Background—Segmentation

Market Background—Segmentation (continued)

Market Background—Segmentation (continued)

Market Segmentation

Market Segmentation (continued)

Market Forecasting

Competitive Landscape—Human Plasma-derived Therapeutics: Marketed Products

Competitive Landscape—Human Plasma-derived Therapeutics Market: Pipeline Products

Competitive Landscape—Count of Marketed and Pipeline Products

Competitive Landscape—Key Clinical Trials

Marketed Products Synopsis—Albumin

Marketed Products Synopsis—Other Haematologicals

Marketed Products Synopsis—Other Haematologicals (continued)

Marketed Products Synopsis—Coagulation Factors

Marketed Products Synopsis—Coagulation Factors (continued)

Marketed Products Synopsis—Coagulation Factors (continued)

Marketed Products Synopsis—Coagulation Factors (continued)

Marketed Products Synopsis—Immunoglobulins

Marketed Products Synopsis—Immunoglobulins (continued)

Marketed Products Synopsis—Immunoglobulins (continued)

Marketed Products Synopsis—Immunoglobulins (continued)

Marketed Products Synopsis—Immunoglobulins (continued)

Marketed Products Synopsis—Immunoglobulins (continued)

Pipeline Analysis—Approved

Pipeline Analysis—Phase 3

Pipeline Analysis—Phase 3 (continued)

Pipeline Analysis—Phase 2

Pipeline Analysis—Phase 1

Product Dashboard—ResusixTM, Entegrion, Inc.

Product Dashboard—CINRYZE® (new formulation), Shire

Product Dashboard—BIOSTATE® (new formulation), CSL Behring

Product Dashboard—Gammagard, Baxter

Conclusions and Recommendations

Legal Disclaimer

Plasma—Overview

Plasma—Overview (continued)

The Frost & Sullivan Story

Value Proposition—Future of Your Company & Career

Global Perspective

Industry Convergence

360º Research Perspective

Implementation Excellence

Our Blue Ocean Strategy


Have questions about this research or need deeper insights?
Speak directly with our analytics experts for tailored recommendations.

Recent related industry research

17 Sep 2026   |   Asia Pacific   |   Frost Radar

Frost Radar™: Facility Management in Malaysia, 2026

Malaysia's facility management (FM) market is transitioning from labor-intensive, compliance-driven service delivery to technology-enabled, outcome-oriented, and sustainability-integrated operating models. Competitive differentiation increasingly depends on providers’ ability to combine integrated F...

17 Sep 2026   |   Global   |   Market Research

Growth Opportunities in the Western Europe Consumer eSIM Market, 2026–2029

The consumer eSIM market in Western Europe is growing steadily, supported by the rising availability of eSIM-capable devices, particularly smartphones, and expanding travel-related use cases. However, commercialization has yet to translate into mass adoption. Despite Apple’s global launch of an eSIM...

17 Sep 2026   |   Asia Pacific   |   Frost Radar

Frost Radar™: ASEAN Warehouse Automation System Providers, 2026

Warehouse automation has moved from a discretionary capital project to a core operating capability. ASEAN operators are redesigning fulfillment networks around smaller orders, shorter delivery windows, broader stock keeping unit (SKU) ranges, and sharper demand volatility. Manual operations remain v...

16 Sep 2026   |   North America   |   Customer Research

US Automotive Technicians’ Choice Survey, 2025

The 2025 US Automotive Technicians’ Choice study is an insightful voice-of-customer survey that highlights the tool preferences of automotive aftermarket service technicians. The survey of 400 automotive technicians across the United States used a combination of computer-assisted telephone and compu...

16 Sep 2026   |   Global   |   Market Research

Apple Performance Tracker, Q1 2026

This Frost & Sullivan tracker provides metrics on Apple's quarterly performance (for both unit sales and revenues) for iPads, iPhones, Macs, and other products, such as iPods, Apple TVs, Beats Electronics, and Apple-branded and third-party accessories. It includes historical quarterly data for all t...

 

Purchase includes:
  • Report download
  • Growth Dialog™ with our experts

Growth Dialog™

A tailored session with you where we identify the:
  • Strategic Imperatives
  • Growth Opportunities
  • Best Practices
  • Companies to Action

Impacting your company's future growth potential.

The Chinese pharmaceutical market is expected to be the third-largest in the world in 2013. This research service analyzes various aspects of the Chinese pharmaceutical market between 2007 and 2016. Rising income, improving healthcare infrastructure, and insurance systems are some factors that drive this market. The study discusses in detail the market challenges and opportunities, competitive analysis, offers a revenue forecast, and a list of local company profiles along with their revenue.
More Information
Deliverable Type Market Research
No Index No
Podcast No
Author Sumedha Pareek
WIP Number MAEC-01-00-00-00
Is Prebook No

A Product and Pipeline Analysis of the Human Plasma-derived Therapeutics Market

$6,000.00

Special Price $4,500.00 save 25 %

In stock
SKU
LS00108-AP-MR_16949